| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/17/2002 | EP0857062B1 Method of producing multi-layer medicaments in solid form for oral or rectal administration |
| 04/17/2002 | EP0799035B1 Emulsion suitable for administering a sphingolipid and use thereof |
| 04/17/2002 | EP0794790B1 Localized delivery of factors enhancing survival of transplanted cells |
| 04/17/2002 | EP0760238B1 Percutaneously administrable preparation for treating urination disorder |
| 04/17/2002 | EP0744947B1 Modified-release metronidazole compositions and methods for making and using same |
| 04/17/2002 | EP0740550B1 Use of mometasone furoate for treating airway passage and lung diseases |
| 04/17/2002 | EP0680325B1 Transdermal therapeutic system with galanthamine as active ingredient |
| 04/17/2002 | EP0660708B1 Phospholipids |
| 04/17/2002 | EP0568651B1 Biodegradable polymer blends for drug delivery |
| 04/17/2002 | CN1345245A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/17/2002 | CN1345236A Swallowable tablets with high content of N-acetylcysteine |
| 04/17/2002 | CN1345235A Granulate with high content of L-carnitine or alkanoyl L-carnitine |
| 04/17/2002 | CN1345234A Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
| 04/17/2002 | CN1345233A Pregelatinized starch in controlled release formulation |
| 04/17/2002 | CN1345232A Hydrogel particle formulations |
| 04/17/2002 | CN1345231A Agglomerates by crystallisation |
| 04/17/2002 | CN1345230A Processes for making pharmaceutical oral ECB formulations and compositions |
| 04/17/2002 | CN1345229A Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 04/17/2002 | CN1345224A Composition for cosmetic and dermatological skin care |
| 04/17/2002 | CN1345213A Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 04/17/2002 | CN1344755A Prep. of degradable polymer, pharmaceutical composition containing the same and its use |
| 04/17/2002 | CN1344564A Prepn of polymyxin E sulfate injection |
| 04/17/2002 | CN1344552A Chinese medicine beautifying pellet and its compounding process |
| 04/17/2002 | CN1344546A Kebai Tincture and its prepn and application |
| 04/17/2002 | CN1344539A Superfine active Chinese medicine powder buccal tablet and its making process |
| 04/17/2002 | CN1082818C 1 alpha, 24-(OH)2-V D3-emulsion composition |
| 04/17/2002 | CN1082817C Corticosteroid-containing pharmaceutical compositions |
| 04/17/2002 | CN1082813C Stabized solutions of platinum (II) antitumor agents |
| 04/17/2002 | CN1082812C Parenteral pharmaceutical compositions and containing ammoniumalkyl salts of 2-arylpropionic acids |
| 04/17/2002 | CN1082811C Gelatin capsule with adjusted water activity |
| 04/17/2002 | CN1082794C Formulation and methods of treatment |
| 04/16/2002 | US6372880 High molecular weight copolymer which comprises, as repeating structure units, both succinimide unit and hydroxycarboxylic acid unit |
| 04/16/2002 | US6372876 Use of polyurethanes which are soluble or dispersible in water as aids in cosmetic and pharmaceutical compositions, and polyurethanes which contain polylactic acid polyols as copolymerized units |
| 04/16/2002 | US6372784 Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| 04/16/2002 | US6372760 Stabilized composition comprising antidementia medicament |
| 04/16/2002 | US6372755 Includes at least one of a water soluble antioxidant, a fat soluble antioxidant, a synergist, a sugar and a surfactant |
| 04/16/2002 | US6372753 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 04/16/2002 | US6372720 Liposome fusion and delivery vehicle |
| 04/16/2002 | US6372714 O,o*-ditetradecanoyl-(a-trimethylammonioacetyl)diethanolamine halide, phosphatide and cholesterol |
| 04/16/2002 | US6372498 Applying vibrational energy to cells |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372433 Antisense modulation of inhibitor of DNA binding-1 expression |
| 04/16/2002 | US6372271 Sugar-free dragee chewing sweets |
| 04/16/2002 | US6372266 Medicinal composition for treating dysmenorrhea and endometriosis industrial use |
| 04/16/2002 | US6372260 Incorporation of active substances in carrier matrixes |
| 04/16/2002 | US6372259 Palatable, sustained release drug granules |
| 04/16/2002 | US6372258 Methods of spray-drying a drug and a hydrophobic amino acid |
| 04/16/2002 | US6372256 Hydrogels containing absorbable polyoxaamides |
| 04/16/2002 | US6372255 Tablet for instant and prolonged release of one or more active substances |
| 04/16/2002 | US6372254 Press coated, pulsatile drug delivery system suitable for oral administration |
| 04/16/2002 | US6372253 Rapidly disintegrating methylcellulose tablets |
| 04/16/2002 | US6372252 Containing quantity of medicine in immediate release layer and second portion in release-delay matrix of hydrophilic polymer and water insoluble polymer |
| 04/16/2002 | US6372251 Bioavailability |
| 04/16/2002 | US6372250 Non-invasive gene targeting to the brain |
| 04/16/2002 | US6372249 Senscent cell-derived inhibitors of DNA synthesis |
| 04/16/2002 | US6372246 Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
| 04/16/2002 | US6372245 Plasticized bioerodible controlled delivery system |
| 04/16/2002 | US6372244 Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use |
| 04/16/2002 | US6372243 Perfluoroalkane or fluorohydrocarbons deoxygenated which prevents their damage to the retina or intraocular structures; use such as treating ischemic retinal disorders |
| 04/16/2002 | US6372234 Containing an antibody |
| 04/16/2002 | US6372233 Lotions containing vitamin D3 derivatives |
| 04/16/2002 | US6372227 Oil in water emulsion containing a sterol and a saponin |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | US6372204 Topical composition of unsaturated monoacid/monoacrylamide/polyfunctional monomer copolymer |
| 04/16/2002 | US6372202 Cosmetic composition, in particular a make-up composition, comprising a pigment derived from pyrrolopyrrole |
| 04/16/2002 | US6372201 Nail varnish comprising an aqueous polymer dispersion |
| 04/16/2002 | US6372197 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 04/16/2002 | US6372196 Hemostatically active aerosol composition of polyanhydroglucoronic acids and its salts |
| 04/16/2002 | US6371171 Agglomeration of finely divided powders |
| 04/16/2002 | CA2266629C Taste-masked microcapsule compositions and methods of manufacture |
| 04/16/2002 | CA2186037C New pharmaceutical formulation and process |
| 04/16/2002 | CA2054629C Pharmaceutical composition |
| 04/11/2002 | WO2002029031A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 04/11/2002 | WO2002028929A1 Zwitterionic polymers |
| 04/11/2002 | WO2002028909A1 Starch |
| 04/11/2002 | WO2002028908A1 Pharmaceutically acceptable starch |
| 04/11/2002 | WO2002028887A2 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 04/11/2002 | WO2002028836A1 Novel crystalline forms of a factor xa inhibitor |
| 04/11/2002 | WO2002028521A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | WO2002028436A1 Absorption enhancers |
| 04/11/2002 | WO2002028435A1 Pharmaceutical vehicle |
| 04/11/2002 | WO2002028430A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | WO2002028426A1 Split enveloped virus preparation |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028422A2 Split enveloped virus preparation for intranasal delivery |
| 04/11/2002 | WO2002028420A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | WO2002028404A1 Eye drops |
| 04/11/2002 | WO2002028402A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | WO2002028386A1 Method for preparing microspheres containing a water-soluble substance |
| 04/11/2002 | WO2002028383A1 Delivery system for multi-pharmaceutical active materials at various release rates |
| 04/11/2002 | WO2002028382A1 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
| 04/11/2002 | WO2002028379A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | WO2002028378A1 Combination particles for the treatment of asthma |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028376A2 Chrono delivery formulations and method of use thereof |
| 04/11/2002 | WO2002028375A1 A controlled-release, parenterally administrable microparticle preparation |
| 04/11/2002 | WO2002028374A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | WO2002028373A1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 04/11/2002 | WO2002028372A2 Systemic delivery of compounds through non-invasive bladder administration |
| 04/11/2002 | WO2002028371A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |